CN203616318U - Risk assessment combined detection card for acute myocardial infarction - Google Patents
Risk assessment combined detection card for acute myocardial infarction Download PDFInfo
- Publication number
- CN203616318U CN203616318U CN201320787805.6U CN201320787805U CN203616318U CN 203616318 U CN203616318 U CN 203616318U CN 201320787805 U CN201320787805 U CN 201320787805U CN 203616318 U CN203616318 U CN 203616318U
- Authority
- CN
- China
- Prior art keywords
- test
- strips
- lateral chromatography
- chromatography test
- test strip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The utility model discloses a risk assessment combined detection card for acute myocardial infarction, which relates to the technical field of medical detection items. The risk assessment combined detection card comprises a detection card backboard, an upper cover, a troponin I (TNI) lateral chromatography test strip, a troponin I (TNI) lateral chromatography test strip clamping groove, a myeloperoxidase (MPO) lateral chromatography test strip, a myeloperoxidase (MPO) lateral chromatography test strip and clamping groove, a hypersensitive C-reactive protein (hs-CRP) lateral chromatography test strip and clamping groove, sample feeding holes and display windows, wherein the troponin I (TNI) lateral chromatography test strip, the troponin I (TNI) lateral chromatography test strip clamping groove, the myeloperoxidase (MPO) lateral chromatography test strip, the myeloperoxidase (MPO) lateral chromatography test strip clamping groove, the hypersensitive C-reactive protein (hs-CRP) lateral chromatography test strip, and the hypersensitive C-reactive protein (hs-CRP) lateral chromatography test strip clamping groove are longitudinal arranged on the detection card backboard; the upper cover is arranged at the upper part of the detection card backboard; the sample feeding holes and the display windows are arranged in positions of the upper cover, and the positions correspond to the test strip clamping grooves. According to the risk assessment combined detection card, detection of three important marks having important significance of judging, assessing and predicting doubtful myocardial infarction or high-risk myocardial infarction patients can be achieved at the same time.
Description
Technical field
The utility model relates to medical test item technical field, be specifically related to a kind of risk assessment combine detection card of acute myocardial infarction.
Background technology
The test card of lateral chromatography and golden mark technology can be passed through to detect the body fluid compositions such as blood samples of patients, urine, thereby human body is carried out to the medical test consumptive material of immunoassay.
In prior art, existing each producer test card is all individual event order single deck tape-recorder (install a test-strips in a test card and carry out a project detection) conventionally.While detection in the face of patient's entry, can only detect item by item simultaneously.Waste time and energy on the one hand, also caused on the one hand the waste of consumptive material shell.Also have part producer by disparity items in same test card in same test-strips combination carry out, but because the interference of different antibodies formula and test-strips fluid unstable caused the inaccurate of testing result.
In diagnosis and checking process for heart stalk suspected patient or heart stalk high-risk patient, whether doctor will exist the risk of heart stalk and generation heart stalk to carry out predicting and evaluating to patient at present.In clinical diagnosis, Troponin I is the goldstandard Interventions Requested of diagnosing acute heart stalk, there is very high specificity, if Troponin I (TNI) detects higher than normal critical value, illustrate that patient exists clear and definite myocardial damage, at this moment whether doctor can be that the heart obstructs period of disease according to the comprehensive current patient of judge of the inspections such as patient's symptom and cardiogram; A large amount of clinical literatures think that myeloperoxidase (MPO) detects index and has close relationship for the stability of coronary artery sclerosis patient's atheromatous plaque, are the important risk assessment indexs that acute myocardial infarction may occur after patch that patients with coronary heart disease is atherosis is exacerbated to a certain degree; A large amount of clinical literatures think that hs-CRP (hs-CRP) is also the important predictor of incidence of coronary heart disease risk.These three projects combo inspections have very important diagnosis and evaluating significance for patients with coronary heart disease, doubtful heart stalk patient and acute myocardial infarction high-risk patient: 1. the prediction of incidence of coronary heart disease risk; 2. the risk assessment that plaque comes off or thrombosis causes the heart to obstruct; 3. whether there is the judgement of acute myocardial infarction.Clinical practice test card or test strips all will detect when these three projects are detected conventionally item by item, adopt three test card just can complete.Complex operation, the waste of laboratory consumables and the rising of hospital costs when troublesome poeration, are also caused.
Utility model content
For the deficiency existing in prior art, the utility model object is the risk assessment combine detection card that is to provide a kind of acute myocardial infarction, carry out the detection of Troponin I (TNI), myeloperoxidase (MPO), three projects of hs-CRP (hs-CRP) simultaneously, to help doctor to realize fast, easily, doubtful heart stalk or heart stalk high-risk patient are predicted as follows or judged: 1. the prediction of incidence of coronary heart disease risk; 2. the risk assessment that plaque comes off or thrombosis causes the heart to obstruct; 3. whether there is the judgement of acute myocardial infarction.
To achieve these goals, the utility model is to realize by the following technical solutions: a kind of risk assessment combine detection card of acute myocardial infarction, comprise test card backboard, upper cover, Troponin I (TNI) lateral chromatography test-strips draw-in groove, myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove, well and display window, on test card backboard, parallel longitudinal is provided with Troponin I (TNI) lateral chromatography test-strips draw-in groove, myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove, upper cover is arranged on test card backboard top, on cover corresponding to the position of test-strips draw-in groove and be provided with well and display window.
In described Troponin I (TNI) lateral chromatography test-strips draw-in groove, myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove, be respectively arranged with Troponin I (TNI) lateral chromatography test-strips, myeloperoxidase (MPO) lateral chromatography test-strips, hs-CRP (hs-CRP) lateral chromatography test-strips.Each test-strips is independent test bar; The test-strips of three test items is arranged in parallel; Test-strips puts in order and does not limit.
The test-strips of three described test items has respectively corresponding independent well and display window; And there is a mark of corresponding test-strips in upper cover shell corresponding position.
Described test card is rectangular shape.
The utlity model has following beneficial effect:
One, can carry out risk profile, morbidity Stage evaluation and the diagnosis of heart stalk effectively by projects combo to doubtful heart stalk or heart stalk high-risk patient;
Two, prevent that by projects combo doctor from omitting Interventions Requested;
Three, combination project operation is more simple and convenient, and naked eyes interpretation or instrument interpretation are all more convenient efficient than traditional single deck tape-recorder individual event
The use of four, having saved test card housing, reduces production costs.
Five, test-strips region is independent, in lateral chromatography process between project without any impact, more than what realize entry in same test-strips detection accuracy will be good simultaneously.
Six, test-strips region is independent, and project label is clearer, is not easy erroneous judgement occurs and obscure.
Accompanying drawing explanation
Describe the utility model in detail below in conjunction with the drawings and specific embodiments;
Fig. 1 is structural representation of the present utility model;
Fig. 2 is the structural representation of test card backboard of the present utility model.
Embodiment
For technological means, creation characteristic that the utility model is realized, reach object and effect is easy to understand, below in conjunction with embodiment, further set forth the utility model.
With reference to Fig. 1-2, this embodiment is by the following technical solutions: a kind of risk assessment combine detection card of acute myocardial infarction, comprise test card backboard 1, upper cover 2, Troponin I (TNI) lateral chromatography test-strips draw-in groove 3, myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 4, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 5, well 6 and display window 7, on test card backboard 1, parallel longitudinal is provided with Troponin I (TNI) lateral chromatography test-strips draw-in groove 3, myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 4, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 5, upper cover 2 is arranged on test card backboard 1 top, on upper cover 2, be provided with well 6 and display window 7 corresponding to the position of test-strips draw-in groove.
In described Troponin I (TNI) lateral chromatography test-strips draw-in groove 3, myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove 4, hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove 5, be respectively arranged with Troponin I (TNI) lateral chromatography test-strips, myeloperoxidase (MPO) lateral chromatography test-strips, hs-CRP (hs-CRP) lateral chromatography test-strips.Each test-strips is independent test bar; The test-strips of three test items is arranged in parallel; Test-strips puts in order and does not limit.
The test-strips of three described test items has respectively corresponding independent well and display window; And there is a mark of corresponding test-strips in upper cover shell corresponding position.
Described test card is rectangular shape.
The each test item of this embodiment completes antigen-antibody reaction by corresponding lateral chromatography or gold label test strip after adding test sample, and completes interpretation and the analysis to testing result by naked eyes or instrument.
This embodiment has realized in same test card and can complete for doubtful heart stalk or heart stalk high-risk patient simultaneously and judge, assess, predict three significant important symbol quality testings surveys, and the combination of these three test items can be carried out preliminary state of an illness judgement and risk profile assessment to doubtful heart stalk or heart stalk high-risk patient.The independent test card of these three projects of comparing detects the features such as simple to operate, practical and convenient, quickness and high efficiency, cost that the utlity model has successively.
More than show and described ultimate principle of the present utility model and principal character and advantage of the present utility model.The technician of the industry should understand; the utility model is not restricted to the described embodiments; that in above-described embodiment and instructions, describes just illustrates principle of the present utility model; do not departing under the prerequisite of the utility model spirit and scope; the utility model also has various changes and modifications, and these changes and improvements all fall within the scope of claimed the utility model.The claimed scope of the utility model is defined by appending claims and equivalent thereof.
Claims (4)
1. the risk assessment combine detection card of an acute myocardial infarction, it is characterized in that, comprise test card backboard (1), upper cover (2), Troponin I (TNI) lateral chromatography test-strips and draw-in groove (3), myeloperoxidase (MPO) lateral chromatography test-strips and draw-in groove (4), hs-CRP (hs-CRP) lateral chromatography test-strips and draw-in groove (5), well (6) and display window (7), the upper parallel longitudinal of test card backboard (1) is provided with Troponin I (TNI) lateral chromatography test-strips and draw-in groove (3), myeloperoxidase (MPO) lateral chromatography test-strips and draw-in groove (4), hs-CRP (hs-CRP) lateral chromatography test-strips and draw-in groove (5), upper cover (2) is arranged on test card backboard (1) top, upper cover (2) is upper is provided with well (6) and display window (7) corresponding to the position of test-strips draw-in groove.
2. the risk assessment combine detection card of a kind of acute myocardial infarction according to claim 1, it is characterized in that, described Troponin I (TNI) lateral chromatography test-strips draw-in groove (3), myeloperoxidase (MPO) lateral chromatography test-strips draw-in groove (4), in hs-CRP (hs-CRP) lateral chromatography test-strips draw-in groove (5), be respectively arranged with Troponin I (TNI) lateral chromatography test-strips, myeloperoxidase (MPO) lateral chromatography test-strips, hs-CRP (hs-CRP) lateral chromatography test-strips, each test-strips is independent test bar, the test-strips of three test items is arranged in parallel, test-strips puts in order and does not limit.
3. the risk assessment combine detection card of a kind of acute myocardial infarction according to claim 1, is characterized in that, the test-strips of three test items has respectively corresponding independent well and display window; And there is a mark of corresponding test-strips in upper cover shell corresponding position.
4. the risk assessment combine detection card of a kind of acute myocardial infarction according to claim 1, is characterized in that, described test card is rectangular shape.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320787805.6U CN203616318U (en) | 2013-12-05 | 2013-12-05 | Risk assessment combined detection card for acute myocardial infarction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320787805.6U CN203616318U (en) | 2013-12-05 | 2013-12-05 | Risk assessment combined detection card for acute myocardial infarction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203616318U true CN203616318U (en) | 2014-05-28 |
Family
ID=50768951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320787805.6U Expired - Fee Related CN203616318U (en) | 2013-12-05 | 2013-12-05 | Risk assessment combined detection card for acute myocardial infarction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203616318U (en) |
-
2013
- 2013-12-05 CN CN201320787805.6U patent/CN203616318U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1248311B (en) | Predicting mortality and detecting severe disease | |
| Chen et al. | How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude? | |
| Reindl et al. | Fibroblast growth factor 23 as novel biomarker for early risk stratification after ST-elevation myocardial infarction | |
| RU2016116771A (en) | ADVANCED DEVICE AND METHOD FOR PREGNANCY TESTING | |
| CN104272112B (en) | It is used to help the method and biochip based on biomarker of diagnosis apoplexy | |
| Plebani | Analytical quality: an unfinished journey | |
| CN106872434A (en) | A kind of portable pen type immunofluorescence chromatography detection means | |
| Buchta et al. | Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection | |
| Behan et al. | HbA1c does not always estimate average glucose | |
| Abebe et al. | Accuracy of urine dipsticks, 2-h and 12-h urine collections for protein measurement as compared with the 24-h collection | |
| CN203616318U (en) | Risk assessment combined detection card for acute myocardial infarction | |
| Lin et al. | Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome | |
| CN203616315U (en) | Combined detecting card for coronary heart disease risk assessment | |
| CN202171568U (en) | Calcium detection test strip | |
| CN109030801A (en) | A kind of clinical sample automatic biochemistry analyzer | |
| CN203616317U (en) | Combined test card for acute myocardial infarction (AMI) diagnosis | |
| CN2739640Y (en) | Urine analytic instrument | |
| Li et al. | Lymphocyte‐to‐C‐Reactive Protein Ratio as an Early Sepsis Biomarker for Neonates with Suspected Sepsis | |
| Trampuš-Bakija et al. | Platelet lumiaggregation testing: Reference intervals and the effect of acetylsalicylic acid in healthy adults | |
| CN205958464U (en) | Domestic urine detection appearance | |
| Marlar | Laboratory evaluation of antithrombin, protein C, and protein S | |
| Sasano et al. | Novel measurements of blood coagulability for assessing the risk of thrombosis | |
| CN203616313U (en) | Combined test card for heart disease | |
| Talwalkar | Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis | |
| CN203658363U (en) | Combining detection card for monitoring infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: HUICHUANGYI TAIZHOU MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: BEIJING HUICHUANGYI MEDICAL TECHNOLOGY CO., LTD. Effective date: 20150228 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100176 DAXING, BEIJING TO: 225300 TAIZHOU, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150228 Address after: 225300 Jiangsu province Taizhou City Road East of the new China medicine Chengkou, Yang Road on the north side of G22 building five floor office area Patentee after: HUICHUANGYI TAIZHOU MEDICAL TECHNOLOGY Co.,Ltd. Address before: 301, room 100176, block B, 14 Zhonghe street, Beijing economic and Technological Development Zone, Beijing, Daxing District Patentee before: BEIJING HUICHUANGYI MEDICAL TECHNOLOGY Co.,Ltd. |
|
| DD01 | Delivery of document by public notice |
Addressee: Patent of Huichuang yitaizhou Medical Technology Co.,Ltd. The person in charge Document name: Patent termination notice |
|
| DD01 | Delivery of document by public notice | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140528 Termination date: 20211205 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |